Evidence map›Paper›PMID 35210962›Full record

ArticleJournal of the Medical Library Association : JMLA2022

Retracted publications in pharmacy systematic reviews.

Sarah Jane Brown, Caitlin J Bakker, Nicole R Theis-Mahon

Abstract read
In one paragraph

Article in Journal of the Medical Library Association : JMLA, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Analysis of Retracted Publications in the Diabetes Literature.Medical journal of the Islamic Republic of Iran · 2026
    Article
  5. Article
  6. Article
  7. The importance of rigor in pharmacy research: Challenges and solutions.Research in social & administrative pharmacy : RSAP · 2025
    Article
  8. Article
  9. Plagiarism in Publications: All about Being Fair!The Indian journal of radiology & imaging · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sarah Jane Brownsjbrown@umn.edu, Assistant Librarian, Health Sciences Library, University of Minnesota Libraries, Minneapolis, MN.ORCID 0000-0001-7699-4417
Caitlin J Bakkercjbakker@umn.edu, Associate Librarian, University of Minnesota Libraries, Minneapolis, MN.ORCID 0000-0003-4154-8382
Nicole R Theis-Mahontheis025@umn.edu, Associate Librarian, Health Sciences Library, University of Minnesota Libraries, Minneapolis, MN.ORCID 0000-0002-6913-5195

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveSystematic reviews and other evidence syntheses, the pinnacle of the evidence pyramid, embody comprehensiveness and rigor; however, retracted data are being incorporated into these publications. This study examines the use of retracted publications in the field of pharmacy, describes characteristics of retracted publications cited by systematic reviews, and discusses factors associated with citation likelihood.

methodsUsing data from Retraction Watch, we identified retracted publications in the pharmacy field. We identified all articles citing these retracted publications in Web of Science and Scopus and limited results to systematic reviews. We classified the retraction reason, determined whether the citation occurred before or after retraction, and analyzed factors associated with the likelihood of systematic reviews citing a retracted publication.

resultsOf 1,396 retracted publications, 283 were cited 1,096 times in systematic reviews. Most (65.0%) (712/1096) citations occurred before retraction. Citations were most often to items retracted due to data falsification or manipulation (39.2%), followed by items retracted due to ethical misconduct including plagiarism (30.4%), or concerns about or errors in data or methods (26.2%). Compared to those not cited in systematic reviews, cited items were significantly more likely to be retracted due to data falsification and manipulation, were published in high impact factor journals, and had longer delays between publication and retraction.

conclusionsFurther analysis of systematic reviews citing retracted publications is needed to determine the impact of flawed data. Librarians understand the nuances involved and can advocate for greater transparency around the retraction process and increase awareness of challenges posed by retractions.

Indexed as

PharmacyScientific MisconductBibliometricsPlagiarismSystematic Reviews as Topicevidence-based pharmacy practicepharmacypublishingresearchretraction of publication as topicsystematic reviews as topic

Identifiers

PMID35210962
PMCPMC8830339

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.